Ernexa Therapeutics Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-3.30 | — | — | Miss |
| Q22026 FY2026 | $-3.30 | $-3.40 | -3.0% | Miss |
| Q12026 FY2026 | — | $-6.95 | — | Miss |
| Q42025 FY2025 | — | $-0.01 | — | Miss |
Back to ERNA overview · ERNA holders · ERNA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.